Data set containing historical information for placebo arm of a phase II proof-of-concept trial for the treatment of ulcerative colitis. The primary outcome is remission at week 8 (binary).
References
Neuenschwander B, Capkun-Niggli G, Branson M, Spiegelhalter DJ (2010). “Summarizing historical information on controls in clinical trials.” Clinical Trials, 7(1), 5–18. doi:10.1177/1740774509356002 .